AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimijoy MF 3mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

Vjovis Health Care Private Limited

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Glimijoy MF 3mg/1000mg Tablet

Diabexe Duo 3mg/1000mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabexe Duo should be administered with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications such as nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication forms part of a comprehensive diabetes management plan that includes dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to effective diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms like sweating, vertigo, cephalalgia, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Glimijoy MF 3mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of Glimijoy MF 3mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the Glimijoy MF 3mg/1000mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimijoy MF 3mg/1000mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimijoy MF 3mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimijoy MF 3mg/1000mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Glimijoy MF 3mg/1000mg Tablet works:

Combining glimepiride (3mg) and metformin (1000mg), Glimijoy MF tablets offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, works through a threefold mechanism: decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimijoy MF 3mg/1000mg Tablet with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glimijoy MF 3mg/1000mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimijoy MF 3mg/1000mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimijoy MF 3mg/1000mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimijoy MF 3mg/1000mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimijoy MF 3mg/1000mg tablets to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. In patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Glimijoy MF 3mg/1000mg tablet dosage; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Glimijoy MF 3mg/1000mg Tablet :

Should you forget a Glimijoy MF 3mg/1000mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimijoy MF 3mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimijoy MF 3mg/1000mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimijoy MF 3mg/1000mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glimijoy MF 3mg/1000mg Tablets and seek immediate medical attention.
Glimijoy MF 3mg/1000mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is unsuitable for type 1 diabetes.
Glimijoy MF 3mg/1000mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Glimijoy MF 3mg/1000mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimijoy MF 3mg/1000mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimijoy MF 3mg/1000mg tablets with alcohol is unsafe. Alcohol can worsen the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Glimijoy MF 3mg/1000mg Ta...
148
MRP 171
13% off